Comparison of Serum Concentrations between Posaconazole Delayed-release Tablet and Oral Suspension at a Large Academic Medical Center

Study goal Evaluate differences between PCZ serum concentrations in patients receiving the DRT versus the OS and in patients receiving higher doses than 300 mg/day of the DRT Study design • Retrospective cohort study Inclusion criteria • Adult patients at Cleveland Clinic Health System • In-patient administration of posaconazole from July 1, 2014 through December 31, 2014 Patient groups • Divided and analyzed based on dosage form and dose of PCZ Contact information: Sarah Welch, Pharm.D. 9500 Euclid Ave. HB-65 Cleveland, OH, 44195 Email: welchs@ccf.org